Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice

被引:86
作者
Li, X
Pilbeam, CC
Pan, L
Breyer, RM
Raisz, LG [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Div Endocrinol Metab MC1850, Dept Med, Farmington, CT 06030 USA
[2] Pfizer Inc, Pfizer Cent Res, Groton, CT 06340 USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
关键词
EP2; receptor; EP4; receptor activator of nuclear factor-kappa B ligand (RANKL); osteoprotegetin (OPG); macrophag colony stimulating factor (M-CSF) interleukin-6 (IL-6);
D O I
10.1016/S8756-3282(02)00683-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have shown that stimulation of osteoclastogenesis in cocultures of osteoblasts and spleen cells in response to prostaglandin E-2 (PGE(2)) is markedly decreased when the osteoblasts are derived from cells lacking either the EP2 or the EP4 receptor. Induction of osteoclast formation requires upregulation of receptor activator of nuclear factor-kappaB ligand (RANKL) on cells of the osteoblastic lineage, which then binds to the RANK receptor on cells of the osteoclast lineage. Osteoprotegerin (OPG) is a decoy receptor for RANKL that can block its interaction with RANK. In addition, macrophage-colony stimulating factor (M-CSF) is essential for osteoclast formation. Finally, PGE(2) can increase interleukin-6 (IL-6), which may further enhance osteoclastogenesis. To study the relative influence of the EP2 and EP4 receptors on response of these factors to PGE(2), we examined mRNA levels for RANKL, OPG, M-CSF, and IL-6 in primary osteoblastic cell cultures derived from two lines of EP2 knockout mice (EP2-/-) and one line of EP4 knockout mice (EP4-/-) and the relevant wild-type controls (EP2+/+ and EP4+/+). The responses of cells from wild-type animals of all three lines were similar. After PGE(2) treatment, RANKL mRNA levels were increased at 2 h, and this was sustained over 72 h. Basal RANKL expression was moderately reduced in EP2-/- cells and markedly reduced in EP4-/- cells. PGE(2) increased RANKL mRNA in EP2-/- cells and EP4-/- cells, but the levels were significantly reduced compared with wild-type cells. There were no consistent changes in expression of M-CSF or OPG in the different genotypes or with PGE(2) treatment. IL-6 mRNA was variably increased by PGE(2) in both wild-type and knockout cells, although the absolute levels were somewhat lower in both EP2-/- and EP4 -/- cultures. Parathyroid hormone (PTH) increased RANKL and IL-6 and decreased OPG mRNA levels similarly in both wild-type and EP2-/- or EP4-/- cells. The major defect in the response to PGE(2) in animals lacking either EP2 or EP4 receptors is a reduction in basal and stimulated RANKL levels. Loss of EP4 receptor appears to have a greater effect on basal RANKL expression than EP2. (Bone 30:567-573; 2002) (C) 2002 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:567 / 573
页数:7
相关论文
共 29 条
[1]   Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells [J].
Brändström, H ;
Björkman, T ;
Ljunggren, Ö .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (03) :831-835
[2]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[3]  
COLEMAN RA, 1995, ADV PROSTAG THROMB L, V23, P283
[4]   Differential stimulation by PGE2 and calcemic hormones of IL-6 in stromal/osteoblastic cells [J].
Gruber, R ;
Nothegger, G ;
Ho, GM ;
Willheim, M ;
Peterlik, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (03) :1080-1085
[5]   MACROPHAGE COLONY STIMULATING FACTOR (M-CSF) IS ESSENTIAL FOR OSTEOCLAST FORMATION INVITRO [J].
HATTERSLEY, G ;
OWENS, J ;
FLANAGAN, AM ;
CHAMBERS, TJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (01) :526-531
[6]   Prostaglandin E2 induces expression of receptor activator of nuclear factor-κB ligand/osteoprotegrin ligand on pre-B cells:: Implications for accelerated osteoclastogenesis in estrogen deficiency [J].
Kanematsu, M ;
Sato, T ;
Takai, H ;
Watanabe, K ;
Ikeda, K ;
Yamada, Y .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (07) :1321-1329
[7]   OVARIECTOMY ENHANCES AND ESTROGEN REPLACEMENT INHIBITS THE ACTIVITY OF BONE-MARROW FACTORS THAT STIMULATE PROSTAGLANDIN PRODUCTION IN CULTURED MOUSE CALVARIAE [J].
KAWAGUCHI, H ;
PILBEAM, CC ;
VARGAS, SJ ;
MORSE, EE ;
LORENZO, JA ;
RAISZ, LG .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :539-548
[8]   Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor [J].
Kennedy, CRJ ;
Zhang, YH ;
Brandon, S ;
Guan, YF ;
Coffee, K ;
Funk, CD ;
Magnuson, MA ;
Oates, JA ;
Breyer, MD ;
Breyer, RM .
NATURE MEDICINE, 1999, 5 (02) :217-220
[9]   Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells [J].
KleinNulend, J ;
Burger, EH ;
Semeins, CM ;
Raisz, LG ;
Pilbeam, CC .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (01) :45-51
[10]   Interleukin-6 synthesis induced by prostaglandin E2:: Cross-talk regulation by protein kinase C [J].
Kozawa, O ;
Suzuki, A ;
Tokuda, H ;
Kaida, T ;
Uematsu, T .
BONE, 1998, 22 (04) :355-360